Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f873c586b280f965dd3090b8370d629 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51f4466834ab915482be36a8806b4cb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa8b328e3008bdd662ed4360c274d69e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fde33b82f0b3e1491fcb72eece18322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7413fa808b46cdc5ead19bca596da58b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3989c079fea8158ec1dcd9ad8fc592e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f378d5e3ba605ce198a0ba9500f4822 |
publicationDate |
2014-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2013235596-A1 |
titleOfInvention |
Combination therapy of a MEK inhibitor and IGF1R inhibitor |
abstract |
The present invention relates to a pharmaceutical combination comprising a MEK inhibitor compound 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)- amide or a pharmaceutically acceptable salt thereof and the IGF1R inhibitor ANTIBODY A, a pharmaceutical composition comprising such combination, methods for treating cancer comprising administration of a therapeutically effective amount of such combination to a subject in need thereof, and uses of such combination for the treatment of cancer. |
priorityDate |
2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |